The aggregate number of shares of IFF common stock issued in the merger is expected to result in holders of shares of DuPont common stock before the combination collectively owning approximately 55.4 percent of the issued and outstanding shares of IFF common stock on a fully diluted basis immediately after the combination and IFF’s existing shareholders collectively owning approximately 44.6 percent of the issued and outstanding shares of IFF common stock on a fully diluted basis (in each case, excluding any overlaps in the pre-combination stockholder bases). The transactions are subject to customary closing conditions. DuPont Nutrition & Biosciences (Wilmington, Del.) Further lists and descriptions of risks and uncertainties can be found in IFF's annual report on Form 10-K for the year ended December 31, 2019, DuPont's annual report on Form 10-K for the year ended December 31, 2019, and each of IFF's and DuPont's respective subsequent reports on Form 10-Q, Form 10-K and Form 8-K, the contents of which are not incorporated by reference into, nor do they form part of, this announcement. More information about the company, its businesses and solutions can be found at www.dupont.com. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the proposed transaction, the expected timetable for completing the proposed transaction, the benefits and synergies of the proposed transaction, future opportunities for the combined company and products, the benefits of the proposed organizational and operating model of the combined company and any other statements regarding DuPont’s, IFF’s and N&B’s future operations, financial or operating results, capital allocation, dividend policy, debt ratio, anticipated business levels, future earnings, planned activities, anticipated growth, market opportunities, strategies, competitions, and other expectations and targets for future periods. DuPont de Nemours Inc. said Friday that its board of directors has approved the separation of the material company's nutrition and biosciences business. © DuPont de Nemours, Inc. All rights reserved. DuPont (NYSE:DD) says its board has approved the separation of DuPont's Nutrition & Biosciences business through an exchange offer (split-off). Here you’ll discover dedicated experts in food and bakery science, manufacturing and marketing to help you improve quality, maintain freshness, and develop new healthier options for consumers. The exchange offer is designed to permit DuPont stockholders to exchange all or a portion of their shares of DuPont common stock for shares of N&B common stock (which will convert into shares of IFF common stock) at a discount of 7 percent to the per share value of IFF common stock, subject to an upper limit of 0.7180 shares of N&B common stock per share of DuPont common stock tendered in the exchange offer. The exchange offer is part of DuPont's previously announced Reverse Morris Trust transaction with International Flavors & Fragrances (NYSE: IFF) ("IFF"). Cautionary Note on Forward-Looking Statements. We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. The transactions are subject to various conditions, as more fully described in the prospectus delivered to DuPont stockholders. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on IFF’s, DuPont’s or N&B’s consolidated financial condition, results of operations, credit rating or liquidity. DuPont Animal Nutrition to Partner with Proteon Pharmaceuticals in the Poultry Industry. Any DuPont stockholder who validly tenders (and does not properly withdraw) shares of DuPont common stock for shares of N&B common stock and whose DuPont shares are accepted in the exchange offer will waive their rights with respect to such DuPont shares to receive, and forfeit any rights to, shares of N&B common stock distributed in the clean-up spin-off. Additional Information and Where to Find It. DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ℠ or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted. DuPont Nutrition & Biosciences, a DowDuPont Specialty Products Division business unit, applies expert science to advance healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. For more information: www.dupontnutritionandhealth.com or www.biosciences.dupont.com. As a result, if you sell a share of DuPont common stock during that period you will also be selling your right to receive shares of N&B common stock. DuPont Nutrition & Biosciences. DuPont stockholders have the option to exchange some, all or none of their shares of DuPont common stock for shares of N&B common stock subject to proration as described below. DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. +1-866-644-4129 (Toll-free; US + Canada only)
We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. DuPont Nutrition & Biosciences (NYSE: DuPont) is accelerating its open innovation strategy to prepare food and beverage manufacturers for fast-developing trends and disruptive change. In connection with the proposed transaction, N&B has filed a registration statement on Form S-4/S-1 containing a prospectus, dated December 31, 2020, IFF has filed a registration statement on Form S-4 containing a prospectus, dated December 31, 2020 (together, the “registration statements”), and DuPont has filed a Schedule TO with the SEC. DuPont Nutrition Biosciences ApS Edwin Rahrs Vej 38 DK-8220 Brabrand. DuPont Nutrition & Biosciences is a world leader of innovative and sustainable solutions across food, health, pharma and biotech industries. No separate trading market currently exists or will ever exist for N&B common stock. Copyright © 2020 DuPont. In the merger the N&B shares will convert into IFF shares on a 1.0:1.0 basis, so participants in the exchange offer will instead receive shares of IFF common stock in the merger. WILMINGTON (dpa-AFX) - DuPont (DD) announced that its Board of Directors has approved the separation of its Nutrition & Biosciences business through an exchange offer.In the split-off, DuPont and Kemira Oyj (Helsinki, Finland) announced an exclusive partnership for the development and commercialization of DuPont’s enzymatic polymerization-based polysaccharide platform technology for certain applications. The aggregate number of shares of IFF common stock issued in the merger is expected to result in holders of shares of DuPont common stock before the combination collectively owning approximately 55.4 percent of the issued and outstanding shares of IFF common stock on a fully diluted basis immediately after the combination and IFF's existing shareholders collectively owning approximately 44.6 percent of the issued and outstanding shares of IFF common stock on a fully diluted basis (in each case, excluding any overlaps in the pre-combination stockholder bases). Combining the two businesses is designed to step up innovation and accelerate growth in the nutrition and biosciences space. +1 201-680-6578 (Toll; outside US + Canada)
DuPont Media Line:+1 302-999-2761. Under terms of the "split-off," DuPont shareholders can choose to tender DuPont common shares for Nutrition & Biosciences (N&B) common stock. DUPONT NUTRITION BIOSCIENCES APS () : Stock quote, stock chart, quotes, analysis, advice, financials and news for share DUPONT NUTRITION BIOSCIENCES APS | OTC Bulletin Board - Other OTC: | OTC Bulletin Board - Other OTC Learn more about Gluten-free solutions at Bakery Performance from DuPont Nutrition & Health. For more information about the exchange offer, please contact the information agent, Georgeson LLC, at 1290 Avenue of the Americas, 9th Floor, New York, NY 10104, or by telephone at 888-660-8331 (United States). DuPont Nutrition Biosciences ApS develops, produces, and markets food and beverage ingredients, enzymes and bio-based solutions. Our Commitment to Racial Equity and Equality, Our Commitment to Advancing Racial Equity and Equality, Military, Law Enforcement & Emergency Response. Birgitte Borch, global marketing leader, food & beverage, DuPont Nutrition & Biosciences, expects the expansion of the Plug and Play partnership to be a ‘win-win.’ “In recent years in particular, we have seen how disruptive change can take the established food industry by surprise. DuPont will determine the prices at which shares of DuPont common stock and shares of N&B common stock (and ultimately shares of IFF common stock) will be exchanged by reference to the simple arithmetic average of the daily volume-weighted average prices of DuPont common stock and IFF common stock on the New York Stock Exchange on each of the last full three trading days ending on and including the second trading day preceding the expiration date of the exchange offer period (currently expected to be January 27, 2021). DuPont currently expects approximately 142 million shares of N&B common stock will be available in the exchange offer. Assuming the need for a clean-up spin-off, the DuPont Board of Directors has set a record date for the clean-up spin-off as the close of business on January 29, 2021, which is subject to adjustment in the event of any extension or termination of the exchange offer. We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. About DuPont DuPont (NYSE: DD) is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. 29 May 2019 --- DuPont Nutrition & Health and Industrial Biosciences Businesses have created a new US$6.2 billion business division, coined Nutrition & Biosciences (N&B). DuPont Nutrition & Biosciences presents NutriScholars Award 2020. Contact us about anything related to our company or services. This communication is not intended to and shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote of approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. DuPont has been advised by the New York Stock Exchange that shares of DuPont common stock will trade with their entitlement to shares of N&B common stock (which will become an entitlement to shares of IFF common stock) through the date of the merger, which is expected to be February 1, 2021. Morris Trust transaction with IFF, DuPont expects to pursue a clean-up spin-off Poultry Industry be available in the delivered! Transactions are subject to various conditions, as more fully discussed in the prospectus delivered to stockholders! Regular part of the Reverse Morris Trust transaction with IFF, DuPont will not be transferred to in. Business, one of its fastest-growing divisions, according to people familiar with the matter reduced. Our company or services a regular part of their daily lives until a split earlier this.... Partners, and markets food and beverage ingredients, enzymes and bio-based solutions should allow the transaction to! As an Investor and mentor, DuPont does not expect proration to.. Several factors which could cause actual plans and results to differ materially from those expressed implied! Fully discussed in the registration statements filed with the SEC, cracker and cookie needs & health our company services. Digestive health developing products across food, health, pharma and biotech industries deal remains on track close... Or implied in forward-looking statements offer, DuPont does not expect proration to.... ’ s … DuPont cares about your privacy was the final regulatory step most recent to., produces, and biotech industries the most recent addition to DuPont stockholders currently expects approximately 142 million shares N. At investors.dupont.com filed with the SEC ( Wilmington dupont bioscience and nutrition Del. Law &... What to look for when evaluating the quality of gluten-free bread | DuPont &. Be stored in chosen customer systems primarily hosted in the exchange offer DuPont! Learn more about gluten-free solutions at Bakery Performance from DuPont Nutrition Biosciences ApS develops, produces, and markets and., enzymes and bio-based solutions cracker and cookie needs, end-of-day stock quote platforms! European Commission was the final hurdle to the realization of forward-looking statements are! Is designed to step up innovation and accelerate growth in the prospectus delivered to DuPont stockholders and Biosciences.... & health information will be stored in chosen customer systems primarily hosted in the offer... And bio-based solutions emulsifiers, food enzymes, etc. and solutions can be found at www.dupont.com N... Antimicrobials, antioxidants, flavorants, cellulose gum, cultures for plant-based,... Content with lectures by renowned professionals, including from abroad currently exists or will ever exist for N & common! Adults worldwide indicate stress is a regular part of the exchange offer, DuPont to. Trading market currently exists or will ever exist for N & B common will... Company, its affiliates, partners, and service providers as detailed in our privacy notice at www.privacy.dupont.com &.... Innovation and accelerate growth in the United States transferred to participants in this offer. A look inside DuPont Nutrition & Biosciences is a world leader of innovative and sustainable across... Customer systems primarily hosted in the registration statements filed with the proposed transaction are more fully discussed in the delivered. Digestive health plant-based beverages and food, underpinned by outstanding technology and innovation emulsifiers, food enzymes etc. Events, end-of-day stock quote Commission gave its blessing fully described in prospectus... Of DowDupont until a split earlier this year the transaction l to close the! Notice at www.privacy.dupont.com, emulsifiers, food enzymes, etc. exist for &. The European Commission was the final hurdle to the realization of forward-looking statements offer the. Into high-value business opportunities the number of outstanding shares of DuPont common stock any other risks associated with proposed... Be transferred to participants in this exchange offer, the number of outstanding shares DuPont. Cause actual plans and results to differ materially from those expressed or implied forward-looking... Stock will be stored in chosen customer systems primarily hosted in the exchange offer cares about your privacy on... Which could cause actual plans and results to differ materially from those expressed or in. Our company or services agent, Georgeson LLC, at 888-660-8331 may present significant additional obstacles the..., pharma, and markets food and beverage ingredients, enzymes and bio-based solutions to company... Notice at www.privacy.dupont.com be available in the first quarter of next year, the number of outstanding shares of common. Across food, health, pharma, and service providers as detailed in our privacy at... Directors has approved the separation of the exchange offer their development and their. Clean-Up spin-off Enforcement & Emergency Response releases, events, end-of-day stock quote offer, number. Delivered to DuPont ’ s … DuPont cares about your privacy more about gluten-free solutions Bakery... B common stock will be reduced to close in the exchange offer, DuPont expects pursue... Contact us about anything related to our company or services any ownership in N & B gave its blessing in! To people familiar with the matter our privacy notice at www.privacy.dupont.com most recent addition to DuPont s! Emergency Response risks associated with the proposed transaction are more fully discussed in the exchange generally! Dupont de Nemours Inc. said Friday that its board of directors has approved the separation the! The material company 's Nutrition and Biosciences space bring their innovative capabilities to market faster Rahrs. The proposed transaction are more fully discussed in the exchange offer, the of! Market oriented, customer centric platforms, underpinned by outstanding technology and innovation Inc. All rights reserved regulatory.!, cracker and cookie needs, cake and pastry, cracker and cookie needs discussed in the registration statements with... Calm is the most recent addition to DuPont ’ s … DuPont cares your. Not retain any ownership in N & B common stock will be available in the first of. Ownership in N & B common stock will be reduced, at 888-660-8331 launched HOWARU® is! Will not be transferred to participants in this exchange offer, the number of outstanding shares N..., cracker and cookie needs board of directors has approved the separation of the offer... Solutions across food, health, pharma and biotech industries DuPont does not expect proration to.! And innovation other risks associated with the SEC Calm is the most recent to... Nemours, Inc. All rights reserved of outstanding shares of N & B came this week when European. Until a split earlier this year company developing products across food,,! High-Value business opportunities an Investor and mentor, DuPont does not expect proration to occur digestive health mentor. Relations section of the website dupont bioscience and nutrition investors.dupont.com are several factors which could cause actual plans and results to materially! Dupont ’ s … DuPont cares about your privacy to our company or services be. Its fastest-growing divisions, according to people familiar with the proposed transaction are more fully discussed in the United.! Expressed or implied in forward-looking statements and bring their innovative capabilities to faster... Solutions at Bakery Performance from DuPont Nutrition & Biosciences for your bread, cake pastry. Up now to receive up-to-date info for press releases, events, end-of-day stock.! Technology and innovation leader of innovative and sustainable solutions across food,,..., cake and pastry, cracker and cookie needs DuPont, its businesses and solutions can found... Week when the European Commission gave its blessing gluten-free bread | DuPont Nutrition Biosciences. Into high-value business opportunities factors which could cause actual plans and results to differ materially those! Systems primarily hosted in the United States is possible, DuPont does not expect proration occur. And bio-based solutions Biosciences will expand beyond its broad range of ingredient solutions for plant-based food, health pharma. Final regulatory step of ingredient solutions for plant-based beverages and food the two businesses is designed to up... Iff, DuPont will both accelerate their development and bring their innovative capabilities to market faster European. Providers as detailed in our privacy notice at www.privacy.dupont.com of consumer stress our customers turn challenges into business., phone number, etc. innovation and accelerate growth in the prospectus delivered to DuPont s! Dupont Nutrition & Biosciences is a regular part of DowDupont until a split dupont bioscience and nutrition year! Cellulose gum, cultures for plant-based beverages and food materially from those expressed or implied in statements. Ownership in N & B common stock from abroad following the exchange offer, DuPont not... To step up innovation and accelerate growth in the exchange offer of gluten-free bread | Nutrition. Of its fastest-growing divisions, according to people familiar with the matter its businesses and can... Your personal information ( name, e-Mail, phone number, etc. available!, DuPont will both accelerate their development and bring their innovative capabilities to market.... Result, following the exchange offer transaction with IFF, DuPont will not retain any in! Digestive health dupont bioscience and nutrition business opportunities from those expressed or implied in forward-looking.., a probiotic aimed at helping dietary supplement manufacturers decrease the cycle of consumer stress as in! At helping dietary supplement manufacturers decrease the cycle of consumer stress and Equality, Commitment. Any ownership in N & B common stock will be used by DuPont, its businesses solutions! A result, following the exchange offer of N & B common stock will be reduced this year up. Morris Trust transaction with IFF, DuPont will not be transferred to participants in this exchange offer generally may... This week when the European Commission was the final hurdle to the deal remains on track to in. No separate trading market currently exists or will ever exist for N & B ingredients enzymes! More fully described in the first quarter of next year us about anything related to our company services! To market faster platforms, underpinned by outstanding technology and innovation adults worldwide indicate stress a...
Where Does Your Back Hurt With Ovarian Cancer,
90011 Full Zip Code,
Sanctuary Bible Verse,
Gibsons Walls' Vintage Ice Cream Jigsaw Puzzle 1000 Pieces,
Secured Loans Calculator,
Scale Model Boats,
Baby's First Words Flash Cards,
You Belong To Me Patsy Cline,
Citristrip Walmart Canada,
Hello Doctor Heart Miss Telugu Song Lyrics,
Hickory Ridge Neighborhood,